Grant Pickering, CHIEF EXECUTIVE OFFICER at Vaxcyte, Inc. (PCVX), sold 13,291 shares at $108.75 ($1.5M) on 2024-10-07, disclosed to the SEC on 2024-10-08.
Scheduled sale ($1.5M) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $107.27 | 310 | $33K | 2.3% |
| 2 | $107.50 | 356 | $38K | 2.6% |
| 3 | $108.72 | 887 | $96K | 6.6% |
| 4 | $108.72 | 887 | $96K | 6.6% |
| 5 | $108.75 | 807 | $88K | 6.0% |
| 6 | $108.75 | 807 |
| $88K |
| 6.0% |
| 7 | $109.43 | 1,849 | $202K | 13.9% |
| 8 | $109.43 | 1,849 | $202K | 13.9% |
| 9 | $109.58 | 2,113 | $232K | 15.9% |
| 10 | $109.58 | 2,113 | $232K | 15.9% |
| 11 | $110.20 | 537 | $59K | 4.1% |
| 12 | $110.20 | 537 | $59K | 4.1% |
| 13 | $110.35 | 239 | $26K | 1.8% |
| Total | $109.28 avg | 13,291 | $1.5M | 100% |
| Filing → |
| PCVX | SELL | 2026-06-18 | $1.2M | — | Filing → |
| PCVX | SELL | 2024-12-10 | $401K | — | Filing → |
| PCVX | SELL | 2024-12-03 | $2.8M | — | Filing → |